Clinical Trial Update: Nalmefene Smoking Cessation Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nalmefene for smoking cessation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Somaxon Pharmaceuticals | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED